Omega-3 Heart Health Claims Decision: FDA Out Of Step With Industry?

"The reality is that the FDA remains unwilling to rely upon a meta-analysis of only the highest quality studies in order to guide its final decision," GOED VP Harry Rice. "I think FDA has really lost sight of how the dietary supplement industry has changed," says attorney Charles Jolly.

FDA words adn building icon

The US Food and Drug Administration's recent decision allowing, at its enforcement discretion, additional qualified health claims for some omega-3 supplements likely reflects its current regard for innovation in the vitamin, mineral and supplement product sector.

The 19 June response to the Global Organization for EPA and DHA Omega-3's citizen petition for health claims for...

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from Regulation

More from Policy & Regulation